1 0

    FDA Drug Approval, A062447, ERYTHROMYCIN

    FDA Drug Approval, A062447, ERYTHROMYCIN

    $149.00 USD
    $149.00 USD
    Sale Sold out

    Contents: Summary Basis of Approval

    ANDA: 062447
    Company: PADAGIS US
    Drug Name: ERYTHROMYCIN
    Active Ingredients: ERYTHROMYCIN
    Strength: 0.5%
    Dosage Form/Route: OINTMENT;OPHTHALMIC
    Action Date: 09/26/1983
    Marketing Status: Discontinued
    Submission Classification: ORIG-1 TE Code: None

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details